Before We Start
What's actually going wrong in preeclampsia
Preeclampsia is a pregnancy-specific hypertensive disorder, generally developing after 20 weeks gestation, thought to originate from abnormal placental development that leads to widespread maternal blood vessel dysfunction (endothelial damage) — this is why preeclampsia isn't simply "high blood pressure during pregnancy" but a systemic condition that can affect the kidneys (proteinuria), liver, brain, and clotting system all at once.
The diagnostic criteria are: blood pressure ≥140/90 on two occasions at least 4 hours apart, plus proteinuria (protein in the urine, reflecting kidney involvement) — after 20 weeks gestation in a patient without a prior history of chronic hypertension. Severe features escalate the diagnosis and urgency significantly: BP ≥160/110, platelets under 100,000, creatinine over 1.1, liver enzymes at twice the normal upper limit, pulmonary edema, severe/persistent headache, visual disturbances, or right upper quadrant pain (from liver involvement/stretching of the liver capsule).
💡 Delivery Is the Only Cure — Everything Else Is Management
Because preeclampsia originates from the placenta itself, the condition does not resolve until the placenta is delivered — every other intervention (blood pressure control, magnesium sulfate for seizure prevention, close monitoring) is aimed at safely stabilizing the mother (and optimizing fetal maturity when gestational age allows) until delivery can occur, not at curing the underlying condition. This framing is essential to understanding why the ultimate management decision always circles back to timing of delivery.
Severity Progression
From preeclampsia to severe features to eclampsia
Preeclampsia (Without Severe Features)
BP ≥140/90 + proteinuria, after 20 weeks
Meets the basic diagnostic threshold without any of the severe features listed above. Management depends heavily on gestational age — close monitoring, possible outpatient management with frequent follow-up, and planning for delivery timing based on both maternal and fetal status.
Preeclampsia With Severe Features
BP ≥160/110, HELLP, visual changes, RUQ pain, and more
Any one of the severe feature criteria escalates management significantly — typically requiring hospitalization, magnesium sulfate for seizure prophylaxis, aggressive blood pressure management, and much closer monitoring with a lower threshold for expedited delivery, since the risk of progression to eclampsia and other complications rises substantially.
Eclampsia
A grand mal seizure — the emergency this entire framework exists to prevent
Eclampsia is the occurrence of a grand mal (tonic-clonic) seizure in a patient with preeclampsia, without another identifiable cause for the seizure. It represents a life-threatening emergency for both mother and fetus. Immediate priorities: protect the patient from injury (padded siderails, do not restrain), maintain airway, administer supplemental oxygen, give (or continue) magnesium sulfate, and notify the provider immediately — delivery is typically expedited once the mother is stabilized.
💊 "Every preeclampsia intervention — magnesium sulfate, BP control, close monitoring — exists to prevent this one moment: the seizure. That's the emergency the whole care plan is built around avoiding."
Treatment
Magnesium sulfate — seizure prophylaxis, treatment, and toxicity monitoring
What Magnesium Sulfate Does
Both prevention and active treatment of seizures
Magnesium sulfate is given for two overlapping purposes: as prophylaxis in preeclampsia with severe features (to prevent a first seizure from occurring), and as active treatment if eclampsia has already occurred (to prevent additional seizures). It is not an antihypertensive — its mechanism relates to reducing neuromuscular excitability and cerebral vasospasm, not directly lowering blood pressure (though blood pressure is managed separately with other medications as needed).
Monitoring for Toxicity
The therapeutic window is narrow — and toxicity has recognizable signs
Magnesium sulfate has a narrow therapeutic range, and toxicity is a real risk requiring close monitoring throughout the infusion. Classic signs of magnesium toxicity, in a progressive pattern: absent deep tendon reflexes (DTRs) — often the earliest reliable sign, checked regularly at the bedside — followed by respiratory depression (RR under 12), and eventually oliguria (urine output under 25–30 mL/hr, since magnesium is renally excreted and reduced output allows it to accumulate further). Serum magnesium levels are also monitored, but the bedside clinical signs (DTRs, respiratory rate, urine output) are checked frequently and don't require waiting for a lab result.
💊 "Absent DTRs → check respiratory rate → check urine output. That's the escalating toxicity pattern, and it's why magnesium sulfate patients get frequent, hands-on bedside checks, not just periodic lab draws."
The Antidote — Calcium Gluconate
Kept at the bedside for any patient receiving magnesium sulfate
Calcium gluconate is the antidote for magnesium sulfate toxicity, directly antagonizing magnesium's effects. It should be readily available at the bedside (not just in the medication room) for any patient on a magnesium sulfate infusion, given the potential for rapid toxicity progression and the need for prompt reversal if severe signs (like significant respiratory depression) develop.
Nursing Environment
Reducing stimuli lowers seizure risk
A quiet, dimly lit room reduces external stimulation that can trigger a seizure in a patient with severe preeclampsia — seizure precautions (padded siderails, suction and oxygen readily available at the bedside) are standard care alongside the pharmacologic management.
🏥 Clinical Scenario — Monitoring Magnesium Sulfate Therapy
A patient with preeclampsia with severe features is receiving a magnesium sulfate infusion for seizure prophylaxis.
Routine Check
The nurse performs the scheduled assessment: DTRs are 2+ (normal), RR is 16, urine output over the last hour was 45 mL. These findings are all within expected/reassuring parameters — no signs of magnesium toxicity. Continue the infusion per protocol and continue scheduled monitoring.
Two Hours Later
DTRs are now absent, RR has dropped to 10, and the patient reports feeling unusually drowsy. This is magnesium toxicity — absent DTRs plus respiratory depression. Priority: stop the magnesium infusion immediately, have calcium gluconate ready to administer per protocol/order, notify the provider, and closely monitor respiratory status and oxygenation.
📌 NCLEX Application
Preeclampsia questions test recognition of severity and magnesium safety:
Diagnostic criteria: "What two findings, together, establish a diagnosis of preeclampsia?" → Blood pressure ≥140/90 (on two occasions 4 hours apart) plus proteinuria, after 20 weeks gestation.
Magnesium toxicity signs: "What is typically the earliest sign of magnesium sulfate toxicity?" → Absent or significantly diminished deep tendon reflexes.
Antidote: "What medication should be readily available at the bedside for a patient receiving magnesium sulfate?" → Calcium gluconate, the antidote for magnesium toxicity.
Only cure: "What is the only definitive treatment for preeclampsia?" → Delivery of the placenta — all other interventions manage and stabilize the condition until delivery is possible.
⚠️ The Trap — Treating Magnesium Sulfate as a Blood Pressure Medication
A common misunderstanding is assuming magnesium sulfate is given to lower blood pressure, since it's used in a hypertensive disorder of pregnancy. In reality, magnesium sulfate's purpose is seizure prophylaxis and treatment — it does not reliably or directly lower blood pressure, which is managed with separate antihypertensive medications when needed. A nurse who expects magnesium sulfate to bring blood pressure down, or who deprioritizes magnesium monitoring because BP looks stable, is missing the actual purpose of the drug.
The safeguard: Keep magnesium sulfate's purpose (seizure prevention/treatment) and monitoring (DTRs, respiratory rate, urine output — toxicity signs) mentally separate from blood pressure management, which is tracked and treated independently.
✓ Quick Self-Test
Answer before checking:
1. What two findings, together, establish a diagnosis of preeclampsia?
2. What is a severe feature of preeclampsia?
3. What is eclampsia, and why does the entire preeclampsia care plan exist to prevent it?
4. What are the three progressive signs of magnesium sulfate toxicity, and which typically appears first?
5. What is the antidote for magnesium sulfate toxicity, and why must it be readily available at the bedside?
Answers:
1. Blood pressure ≥140/90 on two occasions 4 hours apart, plus proteinuria, occurring after 20 weeks gestation.
2. Any of: BP ≥160/110, platelets under 100,000, creatinine over 1.1, liver enzymes at twice normal, pulmonary edema, severe headache, visual disturbances, or RUQ pain.
3. A grand mal seizure occurring in a patient with preeclampsia — it is the life-threatening emergency that magnesium sulfate, close monitoring, and BP management are all aimed at preventing.
4. Absent deep tendon reflexes (typically first), respiratory depression (RR under 12), and oliguria (urine output under 25–30 mL/hr).
5. Calcium gluconate — it must be readily available because magnesium toxicity can progress quickly and requires prompt reversal, particularly if significant respiratory depression develops.
Next Lesson
HELLP Syndrome
→